Gut Microbiota, Deranged Immunity, and Hepatocellular Carcinoma.

GM dysbiosis is integral to liver cancer pathogenesis and treatment response. Its modulation offers promising therapeutic avenues for improving HCC prognosis and response to immunotherapy.